Home »
Home » 12: Evaluating global disparities in clinical trial availability for renal cell carcinoma – PMC
by Ruchi Agarwal, Jaya Goud, Miguel Zugman, Daniela Castro, Xiaochen Li, Koral Shah, Lily Lau, Aaron Lee, Salvador Jaime-Casas, Hedyeh Ebrahimi, Gabriela Regalado-Porras, Sharon Choi, Nora Sobrevilla-Moreno, Erika Ruiz-Garcia, Shivanee Kooner, Skylar Reid, Nasr Chaudhary, Rana McKay, Sumanta Pal & Regina Barragan-Carrillo | Oct 10, 2025 | Articles | 0 Comments
You must be a registered user to view this content for kidney cancer health professionals